wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33434092-79D780E8-B70F-4E5A-B10F-A46D40B46353
Q33434092-79D780E8-B70F-4E5A-B10F-A46D40B46353
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33434092-79D780E8-B70F-4E5A-B10F-A46D40B46353
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial
P2860
Q33434092-79D780E8-B70F-4E5A-B10F-A46D40B46353
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33434092-79D780E8-B70F-4E5A-B10F-A46D40B46353
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
99a7f457f61791f82949e797f09ab863b62408b1
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105